Concepedia

Yu Du

YD

Statistics

Publications

1

Citations

13

H-Index

1

Active since

2023

Affiliations

Fujian Provincial Cancer Hospital(Current)

Yu Du is an author at Fujian Provincial Cancer Hospital specializing in dose-limiting toxicity assessment, immunotherapy, and study phase.

ORCID

Publications per year

2023–2023

1

Publications

1

Phase Ib study of anlotinib in combination with <scp>anti‐PD‐L1</scp> antibody (<scp>TQB2450</scp>) in patients with advanced acral melanoma

Yu Du, Jie Dai, Lili Mao et al. · Journal of the European Academy of Dermatology and Venereology · 2023 · 13 citations

, , +16

1–1 of 1